Lukas Carter

Affiliations: 
Memorial Sloan Kettering Cancer Center, Rockville Centre, NY, United States 
Google:
"Lukas Carter"
Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Mack KN, Samuels ZV, Carter LM, et al. (2024) Interrogating the Theranostic Capacity of a MUC16-Targeted Antibody for Ovarian Cancer. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
Sarrett SM, Rodriguez C, Delaney S, et al. (2024) Evaluating CD133 as a Radiotheranostic Target in Small-Cell Lung Cancer. Molecular Pharmaceutics
Bauer D, Carter LM, Atmane MI, et al. (2023) Pb-Pretargeted Theranostics for Pancreatic Cancer. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
Tully KM, Tendler S, Carter LM, et al. (2022) Radioimmunotherapy Targeting Delta-like Ligand 3 in Small Cell Lung Cancer exhibits antitumor efficacy with low toxicity. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research
Nie P, Kalidindi T, Nagle VL, et al. (2021) Imaging of Cancer γ-Secretase Activity Using an Inhibitor-based PET Probe. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research
Pillarsetty N, Carter L, Lewis JS, et al. (2021) REPLY TO LETTER TO THE EDITOR: POTENTIAL USE OF RADIOLABELED ANTIBODIES FOR IMAGING AND TREATMENT OF COVID-19. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
Dacek MM, Veach DR, Cheal SM, et al. (2021) Engineered Cells as a Test Platform for Radiohaptens in Pretargeted Imaging and Radioimmunotherapy Applications. Bioconjugate Chemistry
Mason CA, Carter LM, Mandleywala K, et al. (2020) Imaging Early-Stage Metastases Using an F-Labeled VEGFR-1-Specific Single Chain VEGF Mutant. Molecular Imaging and Biology
Pillarsetty N, Carter L, Lewis JS, et al. (2020) Oncology-inspired treatment options for COVID-19. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
Gonzales J, Pirovano G, Chow CY, et al. (2020) Fluorescence labeling of a Na1.7-targeted peptide for near-infrared nerve visualization. Ejnmmi Research. 10: 49
See more...